Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study
Serretta, V. ; Corselli, G. ; Piazza, B. ; Lio, D. ; Gervasi, F. ; Salerno, S. ; Pavone-Macaluso, M.
Springer
Published 1993
Springer
Published 1993
| ISSN: |
1434-0879
|
|---|---|
| Keywords: |
Intravesical chemotherapy ; Intravesical immunotherapy ; Interferon-alpha-2b ; Epirubicin ; Interleukins (urinary concentration of)
|
| Source: |
Springer Online Journal Archives 1860-2000
|
| Topics: |
Medicine
|
| Notes: |
Summary A total of 62 patients at high risk for recurrence of superficial bladder cancer were selected for a study designed to compare the prophylactic efficacy of different doses and schedules of sequential intravesical instillations of epirubicin and interferon-alpha-2b and to evaluate which sequence could enhance the release of cytokines in the urine. Our investigations showed a significant increase in urinary concentrations of interleukins in patients who received the sequential intravesical administration of epirubicin and interferon-alpha-2b. Higher urinary concentrations of interleukins and a lower recurrence rate were detected in patients who received interferon-alpha-2b 24 h after epirubicin instillation.
|
| Type of Medium: |
Electronic Resource
|
| URL: |
| _version_ | 1798296059654438912 |
|---|---|
| autor | Serretta, V. Corselli, G. Piazza, B. Lio, D. Gervasi, F. Salerno, S. Pavone-Macaluso, M. |
| autorsonst | Serretta, V. Corselli, G. Piazza, B. Lio, D. Gervasi, F. Salerno, S. Pavone-Macaluso, M. |
| book_url | http://dx.doi.org/10.1007/BF00296836 |
| datenlieferant | nat_lic_papers |
| hauptsatz | hsatz_simple |
| identnr | NLM202603512 |
| issn | 1434-0879 |
| journal_name | Urological research |
| materialart | 1 |
| notes | Summary A total of 62 patients at high risk for recurrence of superficial bladder cancer were selected for a study designed to compare the prophylactic efficacy of different doses and schedules of sequential intravesical instillations of epirubicin and interferon-alpha-2b and to evaluate which sequence could enhance the release of cytokines in the urine. Our investigations showed a significant increase in urinary concentrations of interleukins in patients who received the sequential intravesical administration of epirubicin and interferon-alpha-2b. Higher urinary concentrations of interleukins and a lower recurrence rate were detected in patients who received interferon-alpha-2b 24 h after epirubicin instillation. |
| package_name | Springer |
| publikationsjahr_anzeige | 1993 |
| publikationsjahr_facette | 1993 |
| publikationsjahr_intervall | 8009:1990-1994 |
| publikationsjahr_sort | 1993 |
| publisher | Springer |
| reference | 21 (1993), S. 353-357 |
| schlagwort | Intravesical chemotherapy Intravesical immunotherapy Interferon-alpha-2b Epirubicin Interleukins (urinary concentration of) |
| search_space | articles |
| shingle_author_1 | Serretta, V. Corselli, G. Piazza, B. Lio, D. Gervasi, F. Salerno, S. Pavone-Macaluso, M. |
| shingle_author_2 | Serretta, V. Corselli, G. Piazza, B. Lio, D. Gervasi, F. Salerno, S. Pavone-Macaluso, M. |
| shingle_author_3 | Serretta, V. Corselli, G. Piazza, B. Lio, D. Gervasi, F. Salerno, S. Pavone-Macaluso, M. |
| shingle_author_4 | Serretta, V. Corselli, G. Piazza, B. Lio, D. Gervasi, F. Salerno, S. Pavone-Macaluso, M. |
| shingle_catch_all_1 | Serretta, V. Corselli, G. Piazza, B. Lio, D. Gervasi, F. Salerno, S. Pavone-Macaluso, M. Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study Intravesical chemotherapy Intravesical immunotherapy Interferon-alpha-2b Epirubicin Interleukins (urinary concentration of) Intravesical chemotherapy Intravesical immunotherapy Interferon-alpha-2b Epirubicin Interleukins (urinary concentration of) Summary A total of 62 patients at high risk for recurrence of superficial bladder cancer were selected for a study designed to compare the prophylactic efficacy of different doses and schedules of sequential intravesical instillations of epirubicin and interferon-alpha-2b and to evaluate which sequence could enhance the release of cytokines in the urine. Our investigations showed a significant increase in urinary concentrations of interleukins in patients who received the sequential intravesical administration of epirubicin and interferon-alpha-2b. Higher urinary concentrations of interleukins and a lower recurrence rate were detected in patients who received interferon-alpha-2b 24 h after epirubicin instillation. 1434-0879 14340879 Springer |
| shingle_catch_all_2 | Serretta, V. Corselli, G. Piazza, B. Lio, D. Gervasi, F. Salerno, S. Pavone-Macaluso, M. Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study Intravesical chemotherapy Intravesical immunotherapy Interferon-alpha-2b Epirubicin Interleukins (urinary concentration of) Intravesical chemotherapy Intravesical immunotherapy Interferon-alpha-2b Epirubicin Interleukins (urinary concentration of) Summary A total of 62 patients at high risk for recurrence of superficial bladder cancer were selected for a study designed to compare the prophylactic efficacy of different doses and schedules of sequential intravesical instillations of epirubicin and interferon-alpha-2b and to evaluate which sequence could enhance the release of cytokines in the urine. Our investigations showed a significant increase in urinary concentrations of interleukins in patients who received the sequential intravesical administration of epirubicin and interferon-alpha-2b. Higher urinary concentrations of interleukins and a lower recurrence rate were detected in patients who received interferon-alpha-2b 24 h after epirubicin instillation. 1434-0879 14340879 Springer |
| shingle_catch_all_3 | Serretta, V. Corselli, G. Piazza, B. Lio, D. Gervasi, F. Salerno, S. Pavone-Macaluso, M. Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study Intravesical chemotherapy Intravesical immunotherapy Interferon-alpha-2b Epirubicin Interleukins (urinary concentration of) Intravesical chemotherapy Intravesical immunotherapy Interferon-alpha-2b Epirubicin Interleukins (urinary concentration of) Summary A total of 62 patients at high risk for recurrence of superficial bladder cancer were selected for a study designed to compare the prophylactic efficacy of different doses and schedules of sequential intravesical instillations of epirubicin and interferon-alpha-2b and to evaluate which sequence could enhance the release of cytokines in the urine. Our investigations showed a significant increase in urinary concentrations of interleukins in patients who received the sequential intravesical administration of epirubicin and interferon-alpha-2b. Higher urinary concentrations of interleukins and a lower recurrence rate were detected in patients who received interferon-alpha-2b 24 h after epirubicin instillation. 1434-0879 14340879 Springer |
| shingle_catch_all_4 | Serretta, V. Corselli, G. Piazza, B. Lio, D. Gervasi, F. Salerno, S. Pavone-Macaluso, M. Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study Intravesical chemotherapy Intravesical immunotherapy Interferon-alpha-2b Epirubicin Interleukins (urinary concentration of) Intravesical chemotherapy Intravesical immunotherapy Interferon-alpha-2b Epirubicin Interleukins (urinary concentration of) Summary A total of 62 patients at high risk for recurrence of superficial bladder cancer were selected for a study designed to compare the prophylactic efficacy of different doses and schedules of sequential intravesical instillations of epirubicin and interferon-alpha-2b and to evaluate which sequence could enhance the release of cytokines in the urine. Our investigations showed a significant increase in urinary concentrations of interleukins in patients who received the sequential intravesical administration of epirubicin and interferon-alpha-2b. Higher urinary concentrations of interleukins and a lower recurrence rate were detected in patients who received interferon-alpha-2b 24 h after epirubicin instillation. 1434-0879 14340879 Springer |
| shingle_title_1 | Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study |
| shingle_title_2 | Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study |
| shingle_title_3 | Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study |
| shingle_title_4 | Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study |
| sigel_instance_filter | dkfz geomar wilbert ipn albert fhp |
| source_archive | Springer Online Journal Archives 1860-2000 |
| timestamp | 2024-05-06T09:46:05.254Z |
| titel | Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study |
| titel_suche | Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study |
| topic | WW-YZ |
| uid | nat_lic_papers_NLM202603512 |